APO RESEARCH · REPORT
Erwinase
Erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. It may also be used in other neoplastic conditions where depletion of asparagine might be expected to have a useful effect.
Product & engineering
Understand the product.
Erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. It may also be used in other neoplastic conditions where depletion of asparagine might be expected to have a useful effect.
Selected research
Industry Research
Erwinase Industry Research Report 2026
Market perspective
Erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. It may also be used in other neoplastic conditions where depletion of asparagine might be expected to have a useful effect.
Erwinase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. Erwinase® is indicated for the treatment of Acute Lymphoblastic Leukaemia (ALL), a type of cancer that particularly affects children. Erwinase® is an asparaginase enzyme derived from the bacterium Erwinia chrysanthemi that is used as part of the treatment protocols in conjunction with radiotherapy or chemotherapy. In the last several years, In the past few years, the market has been in a state of insufficient supply. The main reason is that the manufacturer's production status is not stable, and at the same time, some batches of drugs have been damaged due to the contamination of the site.Erwinase is widely sales for Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Others. The most proportion of Erwinase is sales in Acute Lymphoblastic Leukemia, and the consumption proportion is about 95% in 2019.
Report Scope
Read the full market overview
This report quantifies the global Erwinase market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Erwinase Market by Company
Jazz Pharmaceuticals/Porton Biopharma
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech
Erwinase Segment by Type
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Erwinase Segment by Application
Child
Adult
Erwinase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erwinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erwinase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erwinase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Erwinase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Erwinase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Erwinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
Applications
- Child
- Adult
Companies covered
- Jazz Pharmaceuticals/Porton Biopharma
- Shire
- Medac GmbH
- Kyowa Hakko Kirin
- Qianhong Bio-pharma
- Taj Pharmaceuticals
- Mingxing Pharma
- SL Pharma
- United Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Erwinase Market Size (2021-2032)
- 2.2.2 Global Erwinase Sales (2021-2032)
- 2.2.3 Global Erwinase Market Average Price (2021-2032)
- 2.3 Erwinase by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Acute Lymphoblastic Leukemia
- 2.3.3 Acute Myeloid Leukemia
- 2.4 Erwinase by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Child
- 2.4.3 Adult
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Erwinase Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Erwinase Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Erwinase Revenue of Manufacturers (2021-2026)
- 3.4 Global Erwinase Average Price by Manufacturers (2021-2026)
- 3.5 Global Erwinase Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Erwinase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Erwinase, Product Type & Application
- 3.8 Global Manufacturers of Erwinase, Established Date
- 3.9 Global Erwinase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Jazz Pharmaceuticals/Porton Biopharma
- 4.1.1 Jazz Pharmaceuticals/Porton Biopharma Company Information
- 4.1.2 Jazz Pharmaceuticals/Porton Biopharma Business Overview
- 4.1.3 Jazz Pharmaceuticals/Porton Biopharma Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Jazz Pharmaceuticals/Porton Biopharma Erwinase Product Portfolio
- 4.1.5 Jazz Pharmaceuticals/Porton Biopharma Recent Developments
- 4.2 Shire
- 4.2.1 Shire Company Information
- 4.2.2 Shire Business Overview
- 4.2.3 Shire Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shire Erwinase Product Portfolio
- 4.2.5 Shire Recent Developments
- 4.3 Medac GmbH
- 4.3.1 Medac GmbH Company Information
- 4.3.2 Medac GmbH Business Overview
- 4.3.3 Medac GmbH Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Medac GmbH Erwinase Product Portfolio
- 4.3.5 Medac GmbH Recent Developments
- 4.4 Kyowa Hakko Kirin
- 4.4.1 Kyowa Hakko Kirin Company Information
- 4.4.2 Kyowa Hakko Kirin Business Overview
- 4.4.3 Kyowa Hakko Kirin Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kyowa Hakko Kirin Erwinase Product Portfolio
- 4.4.5 Kyowa Hakko Kirin Recent Developments
- 4.5 Qianhong Bio-pharma
- 4.5.1 Qianhong Bio-pharma Company Information
- 4.5.2 Qianhong Bio-pharma Business Overview
- 4.5.3 Qianhong Bio-pharma Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Qianhong Bio-pharma Erwinase Product Portfolio
- 4.5.5 Qianhong Bio-pharma Recent Developments
- 4.6 Taj Pharmaceuticals
- 4.6.1 Taj Pharmaceuticals Company Information
- 4.6.2 Taj Pharmaceuticals Business Overview
- 4.6.3 Taj Pharmaceuticals Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Taj Pharmaceuticals Erwinase Product Portfolio
- 4.6.5 Taj Pharmaceuticals Recent Developments
- 4.7 Mingxing Pharma
- 4.7.1 Mingxing Pharma Company Information
- 4.7.2 Mingxing Pharma Business Overview
- 4.7.3 Mingxing Pharma Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mingxing Pharma Erwinase Product Portfolio
- 4.7.5 Mingxing Pharma Recent Developments
- 4.8 SL Pharma
- 4.8.1 SL Pharma Company Information
- 4.8.2 SL Pharma Business Overview
- 4.8.3 SL Pharma Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SL Pharma Erwinase Product Portfolio
- 4.8.5 SL Pharma Recent Developments
- 4.9 United Biotech
- 4.9.1 United Biotech Company Information
- 4.9.2 United Biotech Business Overview
- 4.9.3 United Biotech Erwinase Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 United Biotech Erwinase Product Portfolio
- 4.9.5 United Biotech Recent Developments
5 Global Erwinase Market Scenario by Region
- 5.1 Global Erwinase Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Erwinase Sales by Region: 2021-2032
- 5.2.1 Global Erwinase Sales by Region: 2021-2026
- 5.2.2 Global Erwinase Sales by Region: 2027-2032
- 5.3 Global Erwinase Revenue by Region: 2021-2032
- 5.3.1 Global Erwinase Revenue by Region: 2021-2026
- 5.3.2 Global Erwinase Revenue by Region: 2027-2032
- 5.4 North America Erwinase Market Facts & Figures by Country
- 5.4.1 North America Erwinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Erwinase Sales by Country (2021-2032)
- 5.4.3 North America Erwinase Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Erwinase Market Facts & Figures by Country
- 5.5.1 Europe Erwinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Erwinase Sales by Country (2021-2032)
- 5.5.3 Europe Erwinase Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Erwinase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Erwinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Erwinase Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Erwinase Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Erwinase Market Facts & Figures by Country
- 5.7.1 South America Erwinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Erwinase Sales by Country (2021-2032)
- 5.7.3 South America Erwinase Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Erwinase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Erwinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Erwinase Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Erwinase Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Erwinase Sales by Type (2021-2032)
- 6.1.1 Global Erwinase Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Erwinase Sales Market Share by Type (2021-2032)
- 6.2 Global Erwinase Revenue by Type (2021-2032)
- 6.2.1 Global Erwinase Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Erwinase Revenue Market Share by Type (2021-2032)
- 6.3 Global Erwinase Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Erwinase Sales by Application (2021-2032)
- 7.1.1 Global Erwinase Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Erwinase Sales Market Share by Application (2021-2032)
- 7.2 Global Erwinase Revenue by Application (2021-2032)
- 7.2.1 Global Erwinase Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Erwinase Revenue Market Share by Application (2021-2032)
- 7.3 Global Erwinase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Erwinase Value Chain Analysis
- 8.1.1 Erwinase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Erwinase Production Mode & Process
- 8.2 Erwinase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Erwinase Distributors
- 8.2.3 Erwinase Customers
9 Global Erwinase Analyzing Market Dynamics
- 9.1 Erwinase Industry Trends
- 9.2 Erwinase Industry Drivers
- 9.3 Erwinase Industry Opportunities and Challenges
- 9.4 Erwinase Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst